Citrate

Type: Keyphrase

Name: Citrate

First reported 13 hours ago - Updated 13 hours ago - 1 reports

Leg Cramps in Pregnancy

Lifestyle Changes Are First-Line Treatment It doesn?t matter if it is day or night. When leg muscles contract suddenly?squeezing your calf with an excruciatingly strong grip?it?s alarming. As the pain subsides, you wonder why you would be so afflicted ... [Published About - 13 hours ago]

Entities: Pregnancy, treatments, Magnesium

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Study of Charge-Dependent Transport and Toxicity of Peptide-Functionalized Silver Nanoparticles Using Zebrafish Embryos and Single Nanoparticle Plasmonic Spectroscopy

Nanomaterials possess unusually high surface area-to-volume ratios and surface-determined physicochemical properties. It is essential to understand their surface-dependent toxicity in order to rationally design biocompatible nanomaterials for a wide variety ... [Published Chemical Research in Toxicology - May 17 2013]

Entities: Spectroscopy, Peptide, Nanoparticle, Embryo, Citrate

First reported May 17 2013 - Updated May 17 2013 - 1 reports

University of Parma

Nanoparticles: Recent Findings from University of Parma Has Provided New Data on Nanoparticles

Today's Medical & Research News2013 MAY 17 -- By a News Reporter-Staff News Editor at Life Science Weekly -- Fresh data on Nanoparticles are presented in a new report. According to news reporting originating in Parma, Italy, by NewsRx journalists, research ... [Published NewsRX - May 17 2013]

Entities: Nanoparticle, University of Parma, Tamoxifen

First reported May 15 2013 - Updated May 16 2013 - 1 reports

Tamoxifen

DARA Reports First Quarter 2013 Financial Results and Operational Highlights

DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today its financial results for the first quarter ended March 31, 2013. The Company also summarized the first ... [Published Zecco - May 15 2013]

Entities: Soltamox, Tamoxifen, Oncology

First reported May 15 2013 - Updated May 15 2013 - 1 reports

Gambro AB

Gambro at the 50th ERA-EDTA Congress in Istanbul – Turkey

Meet up with Gambro at the ERA-EDTA, May 18-21, this year’s highlights will include;Evodial – a unique layer of careEvodial ® is the first and only dialyzer with a heparin-grafted membrane. Clinical trials* have shown that Evodial supports individualization ... [Published MyNewsDesk - May 15 2013]

Entities: Gambro AB, Dialysis, Citrate

First reported May 10 2013 - Updated May 10 2013 - 1 reports

Pfizer Inc

Pfizer Receives CHMP Negative Opinion Regarding Marketing Authorization In Europe For Rheumatoid Arthritis Treatment XELJANZ(R) tofacitinib citrate

(NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- Pfizer Inc. (NYSE: PFE) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for XELJANZ® ... [Published NewsRX - May 10 2013]

Entities: Xeljanz, Tofacitinib, Citrate, Pfizer Inc, Rheumatoid Arthritis

First reported May 09 2013 - Updated May 09 2013 - 1 reports

A Miracle Nutraceutical

Historically, all truly disruptive technologies encounter resistance. I speak often about a few of the most obvious cases. Ignaz Semmelweis, Joseph Goldberger and Barry Marshall and Robin Warren are obvious examples that I talk about regularly.We know, ... [Published Wall Street Pit - May 09 2013]

Entities: Citrate, Thyroiditis, Nutraceuticals

First reported May 07 2013 - Updated May 08 2013 - 2 reports

Keryx: A Small Biotech With Catalysts Galore

The shares of Keryx Pharmaceuticals (KERX) almost tripled in price in the final four days of January, following the January 28th early-morning release of top-line data from a clinical trial assessing its lead (and only) new-drug prospect Zerenex in the ... [Published Seeking Alpha - May 08 2013]

Entities: Zerenex, Keryx Biopharmaceuticals Inc, Dialysis, Patient, Phosphorus

First reported May 06 2013 - Updated May 07 2013 - 3 reports

Keryx Biopharmaceuticals, Inc. Announces First Quarter 2013 Financial Results

The Company will host an investor conference call tomorrow, Wednesday, May 8, 2013In order to participate in the conference call, please call 1-877-869-3847 (U.S.), 1-201-689-8261 (outside the U.S.), call-in ID: KERYX. The audio recording of the conference ... [Published Street Insider - May 07 2013]

Entities: Keryx Biopharmaceuticals Inc, Zerenex, Citrate, New Drug Application, Phosphate

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Fenwal Recalls Anticoagulant Citrate Phosphate Dextrose Solution

4/30/2013Fenwal has initiated an urgent voluntary recall of 1 lot (FM13A15027, product code 4R1584) of Anticoagulant Citrate Phosphate Dextrose Solution, USP (CPD) BLOOD-PACK unit due to an error in which the platelet container is incorrectly labeled ... [Published Facts & Comparisons - May 02 2013]

Entities: Dextrose, Citrate, Anticoagulant, Phosphate

First reported Apr 26 2013 - Updated Apr 26 2013 - 1 reports

ORACIT (Oral Citrate) Liquid [Cardinal Health]

Updated Date: Apr 26, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Apr 26 2013]

Entities: Citrate, Cardinal Health Inc

First reported Apr 25 2013 - Updated Apr 25 2013 - 2 reports

PURE Bioscience Receives Favorable NASDAQ Listing Decision

PURE Bioscience (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that the NASDAQ Listing Qualifications Panel (the "Panel") has granted the Company's request for continued listing on The NASDAQ Capital ... [Published NewsBlaze - Apr 25 2013]

Entities: PURE Bioscience, Citrate, Assay, West Kirkland Mining Inc, Eagle Hill Exploration Corp

Quotes

Michael L Krall, president and CEO, stated: "Based on current market conditions along with the anticipated dilution required to meet the NASDAQ shareholder equity requirement, we believe it is not feasible to regain compliance at this time. We are optimistic about our business progress in various markets and remain committed to increasing shareholder value through the continued execution of our commercialization strategy for SDC-based products. We believe that the OTCQB will provide existing and new shareholders a quality marketplace to trade PURE."

PURE Bioscience Stock to Begin Trading on the OTCQB Marketplace [Published Interest!ALERT - May 17 2013]

According to the news reporters, the research concluded: "Caco-2 cells, used as a model of the intestinal epithelium, were shown to take up the TAM loaded nanoparticles extensively."

Nanoparticles: Recent Findings from University of Parma Has Provided New Data on Nanoparticles [Published NewsRX - May 17 2013]

"I truly believe we have positioned DARA uniquely, have assembled a strong team at the Company and have the opportunity to bring to market important supportive care therapies for cancer patients, and in turn, build significant value for our shareholders" concluded Drutz

DARA Reports First Quarter 2013 Financial Results and Operational Highlights [Published Zecco - May 15 2013]

"In almost all purification methods for AAT discussed above, lipoproteins, including ApoA-I, are discarded as a contaminant, usually being still bound to a lipid removal agent. On the other hand, published purification methods for ApoA-I discard AAT in a mixture with many other plasma proteins."

Patent Issued for Methods for Purification of Alpha-1-Antitr. . . [Published Equities.com - May 15 2013]

More Content

sort by: Date \| Relevance
Dear Dr. Roach: Elevated tsa does not always re... [Published Herald & Review - 8 hours ago]
Bovine blood keeps gold nanoparticles stable [Published Health Canal - 10 hours ago]
Five Kidney Stones You Should Know About and Th... [Published The Guardian Express - 12 hours ago]
Leg Cramps in Pregnancy [Published About - 13 hours ago]
Study of Charge-Dependent Transport and Toxici... [Published Chemical Research in Toxicology - May 17 2013]
PURE Bioscience Stock to Begin Trading on the O... [Published Interest!ALERT - May 17 2013]
PURE Bioscience Stock to Begin Trading on the O... [Published Marketwire - Breaking News Releases - May 17 2013]
US Embassy, USAID Will Attend 14th Conference o... [Published Hondurasweekly - May 17 2013]
Crime rate drops [Published Kelowna Daily Courier - May 17 2013]
Nanoparticles: Recent Findings from University ... [Published NewsRX - May 17 2013]
Concerned about GMOs [Published Kelowna Daily Courier - May 16 2013]
An Interview with Don McLeroy, Part III [Published NeuroLogica Blog - May 16 2013]
Genevieve A. Voigt [Published Ozaukee Press - May 16 2013]
Jennifer L. Lemke-Rude [Published Ozaukee Press - May 16 2013]
Jean Lange [Published Ozaukee Press - May 16 2013]
Jerome H. Kroeger [Published Ozaukee Press - May 16 2013]
Ed Burmeister [Published Ozaukee Press - May 16 2013]
Gerald Wilkens [Published Ozaukee Press - May 16 2013]
MD Introduces the World’s Fastest Notebook Grap... [Published AMD Zone - May 15 2013]
AMD Expands Never Settle Bundle Crysis 3 and To... [Published AMD Zone - May 15 2013]
DARA Reports First Quarter 2013 Financial Resul... [Published Zecco - May 15 2013]
Patent Issued for Methods for Purification of A... [Published Equities.com - May 15 2013]
Researchers Submit Patent Application, "Coated ... [Published Equities.com - May 15 2013]
Does Garcinia Cambogia Burn Fat ~ Health Profes... [Published SBWire - May 15 2013]
Gambro at the 50th ERA-EDTA Congress in Istanbu... [Published MyNewsDesk - May 15 2013]
Bovine blood keeps gold nanoparticles stable [Published Rice University - May 13 2013]
Pfizer Announces 11 Abstracts for Tofacitinib t... [Published Yahoo! Finance - May 13 2013]
Physiology: Studies from Semmelweis University ... [Published NewsRX - May 13 2013]
AMD Transforming Into Gaming Company [Published AMD Zone - May 10 2013]
Pfizer Receives CHMP Negative Opinion Regarding... [Published NewsRX - May 10 2013]